Telo Genomics Corp V.TELO

Alternate Symbol(s): TDSGF

Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. Its clinical studies and product development design includes TeloView SMM, TeloView Test to Predict Patient Resistance to Treatment, development in collaboration with the Mayo Clinic and TeloView Test to monitor minimal residual disease in MM patients. The Company, by combining quantitative analysis of three-dimensional telomeres with molecular biology and artificial intelligence to recognize disease associated genetic instability, is developing products that improve day-to-day care for patients by serving the needs of pathologists, clinicians, academic researchers and drug developers.

TSXV:TELO - Post by User

Telo Genomics Corp

Bullboard Posts

Comment by VanAsh01on Jun 28, 2017 2:03pm

91 Views

Post# 26414954

RE:RE:RE:RE:RE:RE:Now that all the money's gone........

agreed what do these guys expect to finance at .40 ???? spent over 1MM on bad choices for ir and look at stock which should be be a buck if they were pros ... where's the 250K a year advisory board member now who we were told would help out ... counting his money

Bullboard Posts

Changing Europe’s dependency on HREE from China